Acotec Scientific Holdings Limited has announced that it has received regulatory approval from the PRC National Medical Products Administration for its Peripheral High-pressure Balloon Dilation Catheter, Armoni-HP®. This device is intended for use in percutaneous transluminal angioplasty in peripheral blood vessels, including femoral, iliac, and renal vessels, and for treating stenosis in arteriovenous fistulas used for dialysis. The Armoni-HP® features a non-compliant balloon catheter with an ultra-high-strength fiber-composite design, offering reliable clinical performance with a working pressure of up to 40 atm. Acotec plans to initiate marketing activities in the PRC market at an appropriate time. Shareholders and potential investors are advised to exercise due care when dealing with the company's shares.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。